{"id":152,"date":"2026-06-19T04:54:00","date_gmt":"2026-06-19T04:54:00","guid":{"rendered":"https:\/\/medicalcalculatorhub.com\/blog\/?p=152"},"modified":"2026-05-26T04:55:48","modified_gmt":"2026-05-26T04:55:48","slug":"curb-65-score-pneumonia-severity-interpretation","status":"publish","type":"post","link":"https:\/\/medicalcalculatorhub.com\/blog\/2026\/06\/19\/curb-65-score-pneumonia-severity-interpretation\/","title":{"rendered":"CURB-65 Score: How to Calculate and Interpret Pneumonia Severity"},"content":{"rendered":"\n

Quick answer:<\/strong> Score 1 point each for Confusion (new onset), Urea >7 mmol\/L (BUN >20 mg\/dL), Respiratory rate \u226530\/min, Blood pressure (systolic <90 or diastolic \u226460 mmHg), and Age \u226565 years. Total 0\u20135. Score 0\u20131: outpatient. Score 2: consider hospital admission. Score 3\u20135: urgent inpatient care \u2014 30-day mortality exceeds 15\u201340%. Use our free CURB-65 calculator<\/a> for instant scoring and documentation.<\/p>\n\n\n\n

\n\n\n\n

What Is the CURB-65 Score?<\/h2>\n\n\n\n

The CURB-65 is a validated clinical severity scoring system for community-acquired pneumonia (CAP), developed by Lim et al. and endorsed by the British Thoracic Society (BTS) in 2003. It uses five bedside criteria to estimate 30-day mortality risk and guide site-of-care decisions \u2014 specifically whether a patient with pneumonia should be treated as an outpatient, admitted to a general ward, or escalated to ICU-level care.<\/p>\n\n\n\n

CURB-65 was designed to be simpler than the Pneumonia Severity Index (PSI), which requires 20 variables including laboratory values and chest X-ray findings. CURB-65 uses only five criteria, all obtainable at the bedside within minutes of patient contact.<\/p>\n\n\n\n

Who Developed CURB-65 and When<\/h3>\n\n\n\n

Lim WS, van der Eerden MM, Laing R, et al. published the validation study in Thorax<\/em> in 2003 (PMID: 12728155), confirming the score’s predictive accuracy across three prospective cohorts of CAP patients in the UK, New Zealand, and the Netherlands. The BTS endorsed CURB-65 in the same year as the preferred severity scoring tool for CAP in adults.<\/p>\n\n\n\n

\n\n\n\n

The Five CURB-65 Criteria \u2014 Complete Scoring Guide<\/h2>\n\n\n\n

Each criterion scores 1 point if present, 0 if absent. Total possible score: 0\u20135.<\/p>\n\n\n\n

Letter<\/th>Criterion<\/th>Threshold \/ Definition<\/th>How to assess<\/th><\/tr><\/thead>
C<\/strong><\/td>Confusion<\/td>New onset confusion or disorientation<\/td>Test orientation: ask name, date, and location. Use Abbreviated Mental Test Score (AMTS) \u22648 as the formal threshold. New confusion only \u2014 do not score if chronic cognitive impairment is baseline.<\/td><\/tr>
U<\/strong><\/td>Urea (Blood Urea Nitrogen)<\/td>Urea >7 mmol\/L (BUN >20 mg\/dL)<\/td>Blood test. In patients without BUN result, use clinical markers of dehydration or renal impairment as a proxy \u2014 but document that BUN was not available. The CRB-65 (no U) is preferred in primary care when bloods aren’t immediately available.<\/td><\/tr>
R<\/strong><\/td>Respiratory rate<\/td>RR \u226530 breaths per minute<\/td>Count respiratory rate over a full 60 seconds. Do not estimate. Tachypnoea is one of the most sensitive clinical markers of respiratory compromise in pneumonia.<\/td><\/tr>
B<\/strong><\/td>Blood pressure<\/td>Systolic <90 mmHg OR diastolic \u226460 mmHg<\/td>One abnormal BP criterion = 1 point. Either systolic OR diastolic meeting threshold is sufficient \u2014 do not require both.<\/td><\/tr>
65<\/strong><\/td>Age \u226565 years<\/td>Patient is 65 years old or older<\/td>Confirmed from patient record. This criterion reflects the exponentially increased mortality risk of pneumonia in older adults regardless of other presenting features.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Memory aid:<\/strong> CURB-65<\/strong> \u2014 Confused, Uraemic, Rapid breathing, Blood pressure low, 65 or older.<\/p>\n\n\n\n

\n\n\n\n

CURB-65 Score Interpretation \u2014 Mortality and Admission Decisions<\/h2>\n\n\n\n
CURB-65 Score<\/th>Risk Group<\/th>30-day Mortality<\/th>Recommended Action<\/th><\/tr><\/thead>
0<\/strong><\/td>Low<\/td>~0.7%<\/td>Outpatient treatment appropriate in most cases. Ensure adequate follow-up within 24\u201348 hours.<\/td><\/tr>
1<\/strong><\/td>Low<\/td>~2.1%<\/td>Outpatient treatment usually appropriate. Consider short hospital stay if social factors or clinical concerns exist.<\/td><\/tr>
2<\/strong><\/td>Intermediate<\/td>~9.2%<\/td>Consider hospital admission and supervised management. Clinical judgement required \u2014 some CURB-65 score 2 patients may be suitable for outpatient care with close monitoring.<\/td><\/tr>
3<\/strong><\/td>High<\/td>~14.5%<\/td>Urgent hospital admission required. Assess need for ICU review. Begin empirical antibiotics immediately.<\/td><\/tr>
4<\/strong><\/td>High<\/td>~27.0%<\/td>Urgent hospital admission. Strong consideration for ICU or HDU level care. Senior review essential.<\/td><\/tr>
5<\/strong><\/td>Severe<\/td>~27\u201340%+<\/td>Severe CAP. ICU admission should be considered. Aggressive resuscitation, broad-spectrum antibiotics, and monitoring.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Critical clinical caveat:<\/strong> CURB-65 is a decision-support tool, not a replacement for clinical judgement. A patient with CURB-65 score 1 who has rapidly deteriorating oxygenation, bilateral consolidation on chest X-ray, or significant comorbidities may require hospital admission regardless of the low score. Always integrate the score with the full clinical picture.<\/p>\n\n\n\n

\n\n\n\n

CRB-65 \u2014 The Primary Care Version (No Blood Test Required)<\/h2>\n\n\n\n

When blood urea nitrogen is not immediately available (community setting, GP surgery, nursing home), the CRB-65 score can be used. It omits the Urea criterion and scores only four parameters: Confusion, Respiratory rate \u226530, Blood pressure low, Age \u226565. Maximum score: 4.<\/p>\n\n\n\n

CRB-65 Score<\/th>30-day Mortality<\/th>Recommendation<\/th><\/tr><\/thead>
0<\/strong><\/td>~1.2%<\/td>Low risk \u2014 home treatment likely appropriate<\/td><\/tr>
1\u20132<\/strong><\/td>~8.2%<\/td>Intermediate risk \u2014 hospital assessment recommended<\/td><\/tr>
3\u20134<\/strong><\/td>~31%<\/td>High risk \u2014 urgent hospital admission<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
\n\n\n\n

CURB-65 vs PSI \u2014 Which Should You Use?<\/h2>\n\n\n\n
Feature<\/th>CURB-65<\/th>PSI (PORT Score)<\/th><\/tr><\/thead>
Number of variables<\/strong><\/td>5<\/td>20<\/td><\/tr>
Blood tests required<\/strong><\/td>Urea only<\/td>7 laboratory values<\/td><\/tr>
Chest X-ray required<\/strong><\/td>No<\/td>Yes<\/td><\/tr>
Time to calculate<\/strong><\/td>2 minutes bedside<\/td>10\u201315 minutes with labs<\/td><\/tr>
Sensitivity for high-risk patients<\/strong><\/td>96.7% (for ICU admission)<\/td>Slightly lower<\/td><\/tr>
Specificity for low-risk patients<\/strong><\/td>Lower \u2014 may over-admit younger patients<\/td>Better \u2014 more granular risk stratification<\/td><\/tr>
Best setting<\/strong><\/td>Emergency department, acute medicine, ICU triage<\/td>Inpatient care planning, research<\/td><\/tr>
Endorsed by<\/strong><\/td>BTS, NICE, IDSA\/ATS (alongside PSI)<\/td>IDSA\/ATS (alongside CURB-65)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Bottom line:<\/strong> CURB-65 is better for rapid bedside triage and ICU admission prediction. PSI is better for identifying truly low-risk patients who can safely avoid hospitalisation. Both IDSA and ATS recommend using either CURB-65 or PSI \u2014 not one exclusively.<\/p>\n\n\n\n

\n\n\n\n

CURB-65 and COVID-19 Pneumonia \u2014 Important Limitations<\/h2>\n\n\n\n

CURB-65 was validated in bacterial community-acquired pneumonia. Its performance in COVID-19 pneumonia is significantly reduced for three reasons:<\/p>\n\n\n\n

    \n
  1. Silent hypoxaemia:<\/strong> COVID-19 patients frequently present with severe hypoxaemia (SpO\u2082 <90%) without tachypnoea \u2014 the “happy hypoxic” phenomenon. CURB-65 does not include oxygen saturation, so these patients score falsely low.<\/li>\n\n\n\n
  2. Age bias:<\/strong> The age \u226565 criterion over-weights age in COVID-19 where younger adults can develop severe disease, while older adults with mild COVID may be over-admitted.<\/li>\n\n\n\n
  3. Different pathophysiology:<\/strong> COVID-19 pneumonia involves cytokine storm and endothelial injury rather than the bacterial consolidation CURB-65 was designed for.<\/li>\n<\/ol>\n\n\n\n

    For COVID-19 pneumonia, WHO and NICE recommend using SpO\u2082 and the WHO severity classification rather than CURB-65 alone.<\/p>\n\n\n\n

    \n\n\n\n

    Worked Clinical Examples<\/h2>\n\n\n\n

    Example 1 \u2014 Low Risk<\/h3>\n\n\n\n

    55-year-old man with productive cough, fever, and right lower lobe consolidation on CXR. Alert and oriented. BUN 14 mg\/dL. RR 18\/min. BP 128\/82 mmHg.<\/p>\n\n\n\n